|
Volumn 44, Issue 2, 2016, Pages 329-332
|
Commercialization of cellular immunotherapies for cancer
|
Author keywords
CAR T; Cellular therapy; Immunotherapy; Oncology; Solid tumours
|
Indexed keywords
CHIMERIC ANTIGEN RECEPTOR;
ARTICLE;
CANCER IMMUNOTHERAPY;
DRUG COST;
DRUG MANUFACTURE;
DRUG MARKETING;
HEMATOLOGY;
HUMAN;
ONCOLOGY;
PRIORITY JOURNAL;
REIMBURSEMENT;
SOLID TUMOR;
COMMERCIAL PHENOMENA;
DRUG INDUSTRY;
IMMUNOTHERAPY;
NEOPLASM;
ORGANIZATION AND MANAGEMENT;
COMMERCE;
DRUG COSTS;
DRUG INDUSTRY;
HUMANS;
IMMUNOTHERAPY;
NEOPLASMS;
REIMBURSEMENT MECHANISMS;
|
EID: 85009819841
PISSN: 03005127
EISSN: 14708752
Source Type: Journal
DOI: 10.1042/BST20150240 Document Type: Article |
Times cited : (20)
|
References (6)
|